Bull/Bear Struggle Continues<br />By Rev Shark<br />RealMoney.com Contributor<br />8/14/2008 9:12 AM EDT <br /><br />--Bernice Johnson Reagon <br /><br />Despite a pretty good rally over the last couple of weeks, the market still faces substantial challenges. The bulls have been arguing that the worst is over for banks, lower oil and commodity prices will reduce inflation and empower the consumer and, most importantly, that we have fully priced in a struggling economy. These ideas have been embraced widely enough to give us a decent move off the mid-July lows and to produce some favorable technical action. <br /><br />The bear's response here is not a big surprise. They tell us that the bulls are ahead of things once again and are just doing the same thing they always do in a bear market. They are prematurely hopeful, looking past the many great challenges that are still out there and ignoring the repercussions of some of the worst economic issues in many decades. <br /><br />I tend to side with the bears and, as I've stated, I believe that the market is simply enjoying a bear-market bounce. We are still holding up pretty well, and it was impressive that higher crude oil prices didn't hurt the market more Wednesday. Nonetheless, I believe the upside here is limited and that the weight of our problems will eventual hit us again, especially when navigating seasonal weakness. <br /><br />Regardless of the big picture, the market has been very tough on traders lately, unless you have a very short time frame. We continue to have very choppy trading and are hypersensitive to any move in crude oil, which means that most trades lately are nothing more than a bet on the direction of oil. <br /><br />We had higher than expected CPI and unemployment, which has turned the premarket action negative. There is no question these numbers are a disappointment and one of the big challenges the market has to deal with. It is going to be very instructive today to see how the market contends with this, especially if oil continues the bounce that started Wednesday. <br /><br />Snap on your trading helmet and adjust your goggles, it's going to be a tricky one. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: VM +9.5%, EL +6.8%, ASYS +6.5%, IOC +6.4%, CLNE +1.8%... M&A news: HLYS +14.4% (SKX proposes to acquire co for $5.25 a share)... Select metals/mining stocks showing modest strength: BBL +3.2%, ACH +2.9%, BHP +2.9%, AAUK +2.2%, GOLD +1.9%, AUY +1.9%, AU +1.5%... Other news: PMI +25.4% (announces that it has entered into a definitive agreement to sell its Australian mortgage insurance subsidiary and related Australian holding co to QBE Insurance Group), IDEV +9.1% (announces the issuance of U.S. Patent No. 7,410,978 , entitled "Once Daily Dosage Forms of Trospium"), IVZ +7.6% (will replace IACI in S&P 500 after the close on 8/20), GMKT +4.5% (continued strength following yesterday's ~15% surge), GILT +4.2% (provides update on merger transaction following 16% decline in yesterday's afternoon trading; cos questioning whether all of the conditions of the merger agreement have been met), BKE +3.4% (will replace WHQ in S&P 600 after the close on 8/19), CROX +2.9% (up in sympathy with HLYS), UBS +2.9% (plans to focus on India, Russia, Brazil, Kurer tells Sole - Bloomberg.com), SCL +1.4% (will replace BLG in S&P 600 after the close on 8/19), LCAPA +1.3% (approves up to $300 mln share repurchase authorization), GPRO +1.2% (FDA grants full approval of PROCLEIX ULTRIO blood screening assay), TS +1.0% (still checking)... Analyst comments: KGC +3.3% (upgraded to Buy at Canaccord), DE +1.6% (upgraded to Buy at Stifel), JEC +1.4% (upgraded to Buy at Stifel), CREE +1.2% (initiated with a Buy at Cantor Fitzgerald).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: PMII -52.0%, LYTS -34.2% (also downgraded to Underperform at Baird), SPRD -20.5%, GRRF -16.7%, BGG -11.6%, GSOL -10.9% (light volume), COIN -9.4%, PAET -6.2%, IPI -5.3%, NTAP -4.2%, MDAS -2.0%, PMTI -1.8%... Select European financials showing weakness: ING -3.8% (trading ex-dividend), BCS -3.4% (may write down 1.5 billion pounds more, says Goldman - Reuters.com), RBS -3.2%... Other news: BSX -5.8% (Heart stents' advantage over drugs fades with time, study says - Bloomberg.com), TRLG -3.4% and NOK -1.1% (still checking)... Analyst comments: CPHD -5.5% (downgraded to Neutral at UBS), OVTI -5.0% (downgraded to Neutral from Outperform at Robert W. Baird), CT -3.7% (downgraded to Sell at UBS), ASML -2.6% (downgraded to Hold at ING - Bloomberg), GD -1.8% (downgraded to Neutral at JPMorgan), CS -1.4% (downgraded to Underperform at Merrill), LPNT -1.3% (downgraded to Mkt Perform at Leerink Swann), MDR -1.3% (downgraded to Hold at Citigroup).